GSA CAPITAL PARTNERS LLP - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2022$361,000
-55.5%
639,937
-11.6%
0.05%
-50.5%
Q1 2022$811,000
-20.2%
724,202
+4.0%
0.11%
-14.8%
Q4 2021$1,016,000
-27.5%
696,115
+48.9%
0.13%
-10.5%
Q3 2021$1,402,000
+46.8%
467,371
+127.0%
0.14%
+33.6%
Q2 2021$955,000
+809.5%
205,882
+576.4%
0.11%
+494.4%
Q3 2020$105,00030,4390.02%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$8,237,0009.91%
Invus Financial Advisors, LLC 1,094,998$5,738,0002.40%
Founders Fund V Management, LLC 491,751$2,577,0000.66%
ALGERT GLOBAL LLC 51,890$272,0000.08%
Arbor Wealth Management, LLC 25,888$136,0000.05%
Moloney Securities Asset Management, LLC 41,950$220,0000.05%
PDT Partners, LLC 78,800$413,0000.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,957$2,070,0000.02%
Fort Point Capital Partners LLC 10,000$52,0000.01%
Baillie Gifford 3,803,014$19,928,0000.01%
View complete list of UNITY BIOTECHNOLOGY INC shareholders